Portola Valley, CA, United States of America

Wilfred A Skinner


Average Co-Inventor Count = 2.8

ph-index = 7

Forward Citations = 139(Granted Patents)


Location History:

  • Portola Valley, CA (US) (1978 - 1986)
  • Portla Valley, CA (US) (1986)
  • Portola Valey, CA (US) (1987)
  • Menlo Park, CA (US) (1988 - 1995)

Company Filing History:


Years Active: 1978-1995

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Wilfred A Skinner: Innovator in Transdermal Delivery Systems

Introduction

Wilfred A Skinner is a notable inventor based in Portola Valley, CA (US). He has made significant contributions to the field of transdermal delivery systems, holding a total of 9 patents. His work focuses on the innovative methods and compositions for delivering bioactive peptides through the skin.

Latest Patents

Among his latest patents, Skinner has developed a composition and method for the transdermal delivery of bioactive peptides. This composition includes biologically active peptides with a molecular weight of about 5,000 or less, combined with higher alcohols, esters, or higher amides, along with pyrrolidone compounds. Additionally, he has patented a method for percutaneously administering physiologically active agents, which involves applying a physiologically active agent in a carrier system that includes adjuvants, solvents, and moderators.

Career Highlights

Throughout his career, Skinner has worked with prominent companies such as Nitto Electric Industrial Co., Ltd. and SRI International. His innovative approaches have led to advancements in the field of drug delivery, enhancing the effectiveness of therapeutic agents.

Collaborations

Skinner has collaborated with notable professionals in his field, including Jorge Heller and Kenichiro Saito. These partnerships have contributed to the development of his groundbreaking technologies.

Conclusion

Wilfred A Skinner's contributions to transdermal delivery systems have established him as a key figure in the field of innovation. His patents and collaborations reflect his commitment to advancing medical technology and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…